Figure 2.
Vaccine effectiveness of live-attenuated influenza vaccine (LAIV)—estimates from original studies and consolidated estimates. *, LAIV vaccine effectiveness was 82% (95% confidence interval [CI], 14–96) if children were censored when they had received LAIV <7 days before nasal swab, instead of <14 days. **, Effectiveness against any A strains, with A(H1N1)pdm09 predominantly circulating. Abbreviations: CDC, Centers for Disease Control and Prevention; DoD, Department of Defense; SPSN, Sentinel Practitioner Surveillance Network; VE, vaccine effectiveness.

Vaccine effectiveness of live-attenuated influenza vaccine (LAIV)—estimates from original studies and consolidated estimates. *, LAIV vaccine effectiveness was 82% (95% confidence interval [CI], 14–96) if children were censored when they had received LAIV <7 days before nasal swab, instead of <14 days. **, Effectiveness against any A strains, with A(H1N1)pdm09 predominantly circulating. Abbreviations: CDC, Centers for Disease Control and Prevention; DoD, Department of Defense; SPSN, Sentinel Practitioner Surveillance Network; VE, vaccine effectiveness.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close